The data from these studies will inform the next stages of preclinical research, including Good Laboratory Practice (GLP) enabling studies and future clinical development. While InvestingPro ...

Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and ...

Eradivir, a preclinical biotech company ... which is broader than the current standard of care. A research paper titled “Targeted recruitment of immune effector cells for rapid eradication of ...

The European Medicines Agency and Belgium’s Federal Agency for Medicines and Health Products have approved a Phase 2 challenge study on EV25, an antiviral therapeutic from Eradivir. The approval ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...

“His promotion to president and COO reflects our confidence in his ability to lead Mispro into its next phase of growth ... perceptions of preclinical research facilities.

announces that the Biogenix Molecular Research Center in Miami, FL, is recruiting and dosing patients in the ProstACT Global Phase 3 trial 1 of TLX591 for patients with advanced prostate cancer ...

INDIANAPOLIS — GeniPhys, a preclinical-stage company developing regenerative collagen polymeric biomaterials for soft tissue restoration, has been awarded a $500,000 National Science Foundation (NSF) ...

DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on ...